Genome-wide single nucleotide polymorphism arrays as a diagnostic tool in patients with synchronous endometrial and ovarian cancer

International Journal of Gynecological Cancer

Volumn 22, Issue 5, 2012, Pages 725-731

  Ikeda, Yuji ^a   Oda, Katsutoshi ^a   Nakagawa, Shunsuke ^a   Murayama Hosokawa, Satsuki ^a   Yamamoto, Shogo ^b   Ishikawa, Shumpei ^b   Wang, Linghua ^b   Takazawa, Yutaka ^a   Maeda, Daichi ^a   Wada Hiraike, Osamu ^a   Kawana, Kei ^a   Fukayama, Masashi ^a   Aburatani, Hiroyuki ^b   Yano, Tetsu ^a   Kozuma, Shiro ^a   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Endometrial cancer; Genetic diagnosis; Ovarian cancer; SNP arrays; Synchronous carcinomas

Indexed keywords

BETA CATENIN; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLINICAL ARTICLE; COPY NUMBER VARIATION; DIAGNOSTIC VALUE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; GENE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE MARKER; MOLECULAR DIAGNOSIS; OVARY CANCER; PIK3CA GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM ARRAY;

ADULT; BETA CATENIN; DNA COPY NUMBER VARIATIONS; ENDOMETRIAL NEOPLASMS; FEMALE; GENOME, HUMAN; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PTEN PHOSPHOHYDROLASE; RAS PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863653671     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31824c6ea6     Document Type: Article

References (25)

1. Eisner RF, Nieberg RK, Berek JS. Synchronous primary neoplasms of the female reproductive tract. Gynecol Oncol. 1989;33:335-339. (Pubitemid 19148735)
2. Kline RC, Wharton JT, Atkinson EN, et al. Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol. 1990;39:337-346.
3. Ayhan A, Yalcin OT, Tuncer ZS, et al. Synchronous primary malignancies of the female genital tract. Eur J Obstet Gynecol Reprod Biol. 1992;45:63-66.
4. Pearl ML, Johnston CM, Frank TS, et al. Synchronous dual primary ovarian and endometrial carcinomas. Int J Gynaecol Obstet. 1993;43:305-312. (Pubitemid 24008298)
5. Piura B, Glezerman M. Synchronous carcinomas of endometrium and ovary. Gynecol Oncol. 1989;33:261-264. (Pubitemid 19112926)
6. Zaino RJ. FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int J Gynecol Pathol. 2009;28:1-9.
7. Baak JP, Mutter GL, Robboy S, et al. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005;103:2304-2312. (Pubitemid 40686575)
8. Scully RE, Richardson GS, Barlow JF. The development of malignancy in endometriosis. Clin Obstet Gynecol. 1966;9:384-411.
9. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol. 1985;16:28-34. (Pubitemid 15158746)
10. Young RH, Scully RE. Metastatic tumors of the ovary. In: Kurman RJ, Ronnett BM, Ellenson LH, eds. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, NY:Springer; 2002;1063-1068.
11. Fujita M, Enomoto T, Wada H, et al. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am J Clin Pathol. 1996;105:350-359. (Pubitemid 26077377)
12. Irving JA, Catasus L, Gallardo A, et al. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis. Hum Pathol. 2005;36:605-619. (Pubitemid 40922566)
13. Kaneki E, Oda Y, Ohishi Y, et al. Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis. Hum Pathol. 2004;35:1484-1493. (Pubitemid 40017988)
14. Ricci R, Komminoth P, Bannwart F, et al. PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus. Diagn Mol Pathol. 2003;12:71-78. (Pubitemid 36627188)
15. Shenson DL, Gallion HH, Powell DE, et al. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer. 1995;76:650-657.
16. Kennedy GC, Matsuzaki H, Dong S, et al. Large-scale genotyping of complex DNA. Nat Biotechnol. 2003;21:1233-1237. (Pubitemid 37186182)
17. Gorringe KL, Jacobs S, Thompson ER, et al. High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications. Clin Cancer Res. 2007,13:4731-4739. (Pubitemid 47294779)
18. Murayama-Hosokawa S, Oda K, Nakagawa S, et al. Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway. Oncogene. 2010;29:1897-1908.
19. Minaguchi T, Nakagawa S, Takazawa Y, et al. Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium. Cancer Lett. 2007;248:112-122.
20. Ishikawa S, Komura D, Tsuji S, et al. Allelic dosage analysis with genotyping microarrays. Biochem Biophys Res Commun. 2005;333:1309-1314. (Pubitemid 40910145)
21. Oda K, Stokoe D, Taketani Y, et al. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res. 2005;65:10669-10673. (Pubitemid 41713332)
22. Minaguchi T, Yoshikawa H, Oda K, et al. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas. Clin Cancer Res. 2001;7:2636-2642. (Pubitemid 32911365)
23. Oda K, Okada J, Timmerman L, et al. PIK3CA cooperates with other phosphatidylinositol 3-kinase pathway mutations to effect oncogenic transformation. Cancer Res. 2008;68:8127-8136.
24. The Cancer Genome Atlas (TCGA) Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455: 1061-1068.
25. Shoji K, Oda K, Nakagawa S, et al. The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas. Br J Cancer. 2009;101:145-148.